Apoptosis Therapy in Cancer: The First Single-molecule Co-activating p53 and the Translocator Protein in Glioblastoma
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Apoptosis Therapy in Cancer: The First Single-molecule Co-activating p53 and the Translocator Protein in Glioblastoma
Authors
Keywords
-
Journal
Scientific Reports
Volume 4, Issue 1, Pages -
Publisher
Springer Nature
Online
2014-04-23
DOI
10.1038/srep04749
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Concomitant and adjuvant temozolomide of newly diagnosed glioblastoma in elderly patients
- (2013) Timo Behm et al. CLINICAL NEUROLOGY AND NEUROSURGERY
- An antibody-free strategy for screening putative HDM2 inhibitors using crude bacterial lysates expressing GST-HDM2 recombinant protein
- (2013) Barbara Costa et al. Drug Testing and Analysis
- Bevacizumab for the treatment of glioblastoma
- (2013) Sajeel Chowdhary et al. Expert Review of Neurotherapeutics
- New Anticancer Agents Mimicking Protein Recognition Motifs
- (2013) Marco Persico et al. JOURNAL OF MEDICINAL CHEMISTRY
- Rational Design and Binding Mode Duality of MDM2–p53 Inhibitors
- (2013) Felix Gonzalez-Lopez de Turiso et al. JOURNAL OF MEDICINAL CHEMISTRY
- Apoptosis therapy: driving cancers down the road to ruin
- (2013) Douglas R. Green et al. NATURE MEDICINE
- Human Glioblastoma Multiforme: p53 Reactivation by a Novel MDM2 Inhibitor
- (2013) Barbara Costa et al. PLoS One
- Current understanding of the role and targeting of tumor suppressor p53 in glioblastoma multiforme
- (2013) Bryant England et al. TUMOR BIOLOGY
- Targeting the PI3K/AKT/mTOR signaling pathway in glioblastoma: novel therapeutic agents and advances in understanding
- (2013) Arshawn Sami et al. TUMOR BIOLOGY
- Emerging Roles of Mitochondrial p53 and ARF
- (2012) Yoko Itahana et al. CURRENT DRUG TARGETS
- Synthesis and Biological Evaluation of 4-Phenylquinazoline-2-carboxamides Designed as a Novel Class of Potent Ligands of the Translocator Protein
- (2012) Sabrina Castellano et al. JOURNAL OF MEDICINAL CHEMISTRY
- Ordering of the N-Terminus of Human MDM2 by Small Molecule Inhibitors
- (2012) Klaus Michelsen et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Cilengitide: The First Anti-Angiogenic Small Molecule Drug Candidate. Design, Synthesis and Clinical Evaluation
- (2011) Carlos Mas-Moruno et al. Anti-Cancer Agents in Medicinal Chemistry
- Designed Multiple Ligands for Cancer Therapy
- (2011) N. M. O'Boyle et al. CURRENT MEDICINAL CHEMISTRY
- Bioenergetics Pathways and Therapeutic Resistance in Gliomas: Emerging Role of Mitochondria
- (2011) Corinne E. Griguer et al. CURRENT PHARMACEUTICAL DESIGN
- Tertiary amides with a five-membered heteroaromatic ring as new probes for the translocator protein
- (2011) Barbara Cosimelli et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Inhibition of PI3K/mTOR pathways in glioblastoma and implications for combination therapy with temozolomide
- (2011) G. Prasad et al. NEURO-ONCOLOGY
- Activation of p53 by Nutlin-3a Induces Apoptosis and Cellular Senescence in Human Glioblastoma Multiforme
- (2011) Ruth Villalonga-Planells et al. PLoS One
- Privileged scaffolds for library design and drug discovery
- (2010) Matthew E Welsch et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Novel Irreversible Fluorescent Probes Targeting the 18 kDa Translocator Protein: Synthesis and Biological Characterization
- (2010) Sabrina Taliani et al. JOURNAL OF MEDICINAL CHEMISTRY
- Targeting mitochondria for cancer therapy
- (2010) Simone Fulda et al. NATURE REVIEWS DRUG DISCOVERY
- Designing Multiple Ligands – Medicinal Chemistry Strategies and Challenges
- (2009) Richard Morphy et al. CURRENT PHARMACEUTICAL DESIGN
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility
- (2009) Garrett M. Morris et al. JOURNAL OF COMPUTATIONAL CHEMISTRY
- Small-Molecule Inhibitors of the MDM2-p53 Protein-Protein Interaction to Reactivate p53 Function: A Novel Approach for Cancer Therapy
- (2008) Sanjeev Shangary et al. Annual Review of Pharmacology and Toxicology
- From Single- to Multi-Target Drugs in Cancer Therapy: When Aspecificity Becomes an Advantage
- (2008) S. Giordano et al. CURRENT MEDICINAL CHEMISTRY
- PK 11195 differentially affects cell survival in human wild-type and 18 kDa translocator protein-silenced ADF astrocytoma cells
- (2008) Beatrice Chelli et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Anxiolytic-like Effects ofN,N-Dialkyl-2-phenylindol-3-ylglyoxylamides by Modulation of Translocator Protein Promoting Neurosteroid Biosynthesis
- (2008) Federico Da Settimo et al. JOURNAL OF MEDICINAL CHEMISTRY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started